tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
ProMIS Neurosciences target adjusted to $18 from $4 at H.C. Wainwright
PremiumThe FlyProMIS Neurosciences target adjusted to $18 from $4 at H.C. Wainwright
1M ago
ProMIS Neurosciences announces publication on plasma pTau in Alzheimer’s
Premium
The Fly
ProMIS Neurosciences announces publication on plasma pTau in Alzheimer’s
1M ago
Promis Neurosciences Inc trading halted, news pending
Premium
The Fly
Promis Neurosciences Inc trading halted, news pending
2M ago
Promising Advancements in Alzheimer’s Research and Strong Financial Position Support Buy Rating for ProMIS Neurosciences
PremiumRatingsPromising Advancements in Alzheimer’s Research and Strong Financial Position Support Buy Rating for ProMIS Neurosciences
2M ago
ProMIS Neurosciences Reports Increased R&D Costs and Net Loss
Premium
Company Announcements
ProMIS Neurosciences Reports Increased R&D Costs and Net Loss
2M ago
ProMIS Neurosciences reports Q3 EPS (24c) vs 31c last year
Premium
The Fly
ProMIS Neurosciences reports Q3 EPS (24c) vs 31c last year
2M ago
ProMIS Neurosciences files to sell 28.23M common shares for holders
PremiumThe FlyProMIS Neurosciences files to sell 28.23M common shares for holders
4M ago
Promising Outlook for ProMIS Neurosciences’ PMN310 in Alzheimer’s Treatment with Buy Rating and $3.00 Price Target
Premium
Ratings
Promising Outlook for ProMIS Neurosciences’ PMN310 in Alzheimer’s Treatment with Buy Rating and $3.00 Price Target
4M ago
ProMIS Neurosciences Advances Alzheimer’s Trial to Final Phase
Premium
Company Announcements
ProMIS Neurosciences Advances Alzheimer’s Trial to Final Phase
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100